Authors
Latest:
Pimavanserin Safety Data and Future Research: Clive Ballard, MDClive Ballard, MD, spoke on the safety data of pimavanserin, which was presented at the 2021 AAIC meeting, held from July 26-30.
Latest:
Ari Green, MD, MCR: Remyelination in Multiple SclerosisThe medical director of the UCSF Multiple Sclerosis Center discussed the idea behind remyelination and shared his thoughts on what the best shot at developing a therapy might be.
Latest:
Navigating the Shift from Pediatric to Adult Care Systems in Epilepsy: Danielle Andrade, MD, MSc, FRCPCThe director of the Adult Genetic Epilepsy Program at the University of Toronto talked about the critical issues experienced by patients who transition from pediatric to adult care in epilepsy. [WATCH TIME: 9 minutes]
Latest:
Advancing Multiple Sclerosis Diagnosis With the 2024 Criteria Revision: Xavier Montalban, MD, PhDThe chair of neurology at Hospital Universitari Vall d’Hebron talked about the revision of the MS diagnostic criteria that will integrate new evidence, biological markers, and advanced MRI findings to enable earlier and more precise diagnoses. [WATCH TIME: 4 minutes]
Latest:
Deborah Friedman, MD, MPH: Coordinating Care in TelemedicineThe professor of neurology, neurotherapeutics, and ophthalmology at UT Southwestern discussed the need to better coordinate care between providers when telemedicine is being utilized in headache and migraine care.
Latest:
Trevor Dyson-Hudson, MD: Unseen Consequences of Spinal Cord InjuryThe director of the Center for Spinal Cord Injury Research and co-director of the Spinal Cord Injury Model System Center at Kessler Foundation discussed the secondary medical complications of spinal cord injury and how he and colleagues seek to alleviate them.
Latest:
Treating MS: A Simplified Strategy Boosts Patient and Provider SatisfactionBoth the busy clinician and the overwhelmed patient benefit from a pointed approach to disease management.
Latest:
BTKi Treatment ParadigmNeurology experts discuss where BTKi’s fit in the multiple sclerosis treatment continuum.
Latest:
Paul Newhouse, MD: Muscarinic Agonists in Alzheimer TreatmentThe Jim Turner Chair in Cognitive Disorders at the Vanderbilt University School of Medicine shared how the previous muscarinic agonists have better informed the development of this investigational agent, VU319.
Latest:
The “Grave Threat” Posed by the Shortage of NeurologistsWith the physician deficit projected to grow larger within a decade, this global challenge has become a major focus of large organizations and medical societies.
Latest:
Peii Chen, PhD: Addressing Spatial Neglect After StrokeThe senior research scientist at Kessler Foundation offered her personal experience in treating spatial neglect in patients with stroke and potential future treatments on the way.
Latest:
This Week on NeurologyLive® — July 7, 2025Here's some of what is coming soon to NeurologyLive® this week.
Latest:
John Corboy, MD: The DISCO-MS TrialThe professor of neurology at Colorado University spoke about the ongoing phase IV trial to determine the safety of DMT discontinuation in MS.
Latest:
Neurology on the Hill: My Role as an Advocate for NeurologyNeuro-oncology fellow Ashley Aaroe recounts her experience at Neurology on the Hill, advocating for important changes in neurology health care.
Latest:
Steve Chung, MD: Cannabidiol in Tuberous Sclerosis ComplexThe neurologist at Banner-University Medicine Neuroscience Institute offered his perspective on data from an open-label safety assessment of cannabidiol (Epidiolex) in the treatment of tuberous sclerosis complex.
Latest:
Karen J. Nolan, PhD: Functional Implementation of Robotics in NeurorehabilitationThe senior research scientist in the Center for Mobility and Rehabilitation Engineering Research at Kessler Foundation spoke to the research being done into the functional implementation of exoskeletons in neurorehabilitation.
Latest:
Shaun Hussain, MD, MS: Exploring the Connection Between Autism and Infantile SpasmsThe director of Infantile Spasms Program at UCLA Mattel Children’s Hospital discussed why learning more about patients with infantile spasms may lead to further breakthroughs on the origins of autism spectrum disorder.
Latest:
Treatment Challenges for Migraine During Pregnancy: Brian Grosberg, MD, FAHSThe medical director of the Hartford healthcare Headache Center in Connecticut discussed the significance of findings from a study assessing migraine during pregnancy. [WATCH TIME: 4 minutes]
Latest:
Jerome Engel, Jr., MD, PhD on Referring Patients to Epilepsy CentersThe Director of the UCLA Seizure Disorder Center explained the importance of referring patients with seizures to epilepsy centers.
Latest:
Shai Efrati, MD: Assessing Hyperbaric Oxygen Therapy for NeurodegenerationThe director of the Sagol Center for Hyperbaric Medicine and Research at Yitzhak Shamir Medical Center offers takeaways on hyperbaric oxygen therapy.
Latest:
Managing Psychosis in Parkinson Disease: Challenges and OpportunitiesAlthough the indication of pimavanserin has provided some relief, more work remains to improve how physicians diagnose, treat, and manage psychosis symptoms.
Latest:
Bruton Tyrosine Kinase Inhibitors: A New Hope for the Management of Progression in MS?Several therapies are progressing through the development pipeline and have shown promising data, setting up the multiple sclerosis treatment toolbox for possible expansion in coming years.
Latest:
Thomas Leist, MD: Resetting the Immune System With CladribineThe director of the Comprehensive Multiple Sclerosis Center at Thomas Jefferson University discussed the concept of lymphocyte depletion to reset the immune system.
Latest:
Episode 139: Sleep and Seizures: Emerging Insights From AAN 2025Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Nancy Foldvary-Schaefer, DO, FAAN. [LISTEN TIME: 25 minutes]
